Abstract
Objective
To review the accuracy of the pediatric consensus definition of sepsis in term neonates and to determine the definition of neonatal sepsis used.
Study selection
The review focused primarily on pediatric literature relevant to the topic of interest.
Conclusions
Neonatal sepsis is variably defined based on a number of clinical and laboratory criteria that make the study of this common and devastating condition very difficult. Diagnostic challenges and uncertain disease epidemiology necessarily result from a variable definition of disease. In 2005, intensivists caring for children recognized that as new drugs became available, children would be increasingly studied and thus, pediatric-specific consensus definitions were needed. Pediatric sepsis criteria are not accurate for term neonates and have not been examined in preterm neonates for whom the developmental stage influences aberrations associated with host immune response. Thus, specific consensus definitions for both term and preterm neonates are needed. Such definitions are critical for the interpretation of observational studies, future training of scientists and practitioners, and implementation of clinical trials in neonates.
Keywords: Newborn, neonate, term, preterm, sepsis, infection, SIRS, septic shock, definition, consensus
Statement of the problem
Neonatal sepsis results in death or major disability for 39% of those affected even with timely antimicrobial treatment1. The incidence of severe sepsis in newborns doubled (from 4.5 to 9.7 cases per 1,000 births) between 1995 and 20052. The frequency of sepsis during the birth hospitalization varies inversely with gestational age at birth and may reach 60% in the most immature infants3. The short-term economic burden of caring for and hospitalizing these infected infants is staggering and is estimated at approximately $700 million in the US4. Neither the treatment of neonatal sepsis, nor the neurodevelopmental outcomes in surviving infants has changed significantly over the last thirty years despite multiple failed attempts to reduce the burden of infection5,6. These disappointments have occurred in the context of tremendous advances in other areas of newborn care including nutrition, management of respiratory distress and pulmonary hypertension, and therapeutic cooling following hypoxic-ischemic encephalopathy.
Adult and pediatric intensivists currently use consensus definitions for sepsis for goal-based therapeutic interventions7–10. These definitions are critical to facilitate epidemiologic studies, to accurately determine disease incidence, to select patients for clinical trials, to improve training, and ultimately, to improve the delivery of care. The pediatric consensus definition for sepsis, established in 2005, was intended for all children (<18 years old) and including term (≥37 weeks completed gestation) neonates (Supplemental Table 1)7. Preterm neonates (<37 weeks completed gestation) were specifically excluded from the pediatric consensus definitions and neonatal-perinatal subspecialists were not represented among the pediatric consensus experts. To investigate whether the pediatric consensus definitions for systemic inflammatory response syndrome (SIRS) and sepsis applied to term infants, Hofer et al retrospectively examined 476 term neonates and found that the consensus definitions applied to only 53% of cases of culture-positive early-onset sepsis (EOS)11. The authors determined that the sensitivity of more comprehensive clinical and laboratory criteria to define SIRS in the setting of culture-proven EOS (n = 30) was 20% for hypothermia or fever, 43% for abnormal WBC and neutrophil indices, 87% for respiratory signs, and 33% for cardiovascular signs. To date, the accuracy of the pediatric consensus definitions has not been assessed in preterm infants, nor have consensus definitions been developed or tested in this unique developmentally immature population.
How has sepsis been defined in neonates?
There is remarkable heterogeneity among studies regarding the definition of neonatal sepsis (Supplemental Table 1). For example, in 12/42 (29%) selected studies/guidelines single or combinations of laboratory tests were incorporated into the definition of sepsis and included C-reactive protein (CRP) (n=5)12–16, total WBC (n=4)7,12,17,18, metabolic acidosis (n=3)12,18,19, unspecified lab studies (n=2)20,21, I/T ratio (n=3)7,13,18, neutropenia (n=1)13, abnormal fibrinogen (n=1)12, thrombocytopenia (n=1)12, hyperglycemia (n=1)19 and hypoglycemia (n=1)22. In many cases, there was additional variability among lab results defined as abnormal. Clinical findings were integrated in 26/42 (62%) of the selected studies/guidelines and included unspecified signs of sepsis (n=16)14,15,20,21,23–34, cardiovascular signs [tachycardia/bradycardia, hypotension, poor perfusion (n=12)]7,12,13,17–19,22,30,32,35,36, respiratory signs [apnea, cyanosis, tachypnea, need for ventilator, increased oxygen requirement (n=9)]1,7,12,13,17–19,22,35, abnormal temperature [fever or hypothermia (n=7)]7,12,17–19,22,35, central nervous system signs [lethargy, hypotonia, seizure (n=2)]12,22, and feeding problems (n=112). In some reports, neonatal sepsis was defined by the duration of antimicrobial treatment (at least 5 or more days)6,37–39. Thus, there is an unmet need for the development of a consensus definition for sepsis in both preterm and term neonates to be used for future clinical studies.
The pediatric consensus definition of sepsis is SIRS in the presence of or as a result of suspected or proven infection. SIRS requires either 1) abnormal white count [total white blood cell (WBC) increased or decreased for age -or- >10% immature neutrophils] or 2) abnormal core temperature (>38.5° or <36°C)7. Because abnormal WBC indices or an abnormal core temperature are required for the definition of SIRS, we will focus on the predictive accuracy of these tests in term and preterm neonates.
Total leukocyte counts and neutrophil indices are inaccurate to define sepsis in term or preterm neonates
The complete blood count (CBC) with differential is commonly ordered with a sepsis evaluation in the NICU. Many factors can affect the WBC and differential counts including maternal hypertension, the method of delivery, the infant’s sex, age in hours, and the method of blood sampling40. The impact of gestational age on the range of normal WBC indices must also be taken into account. Following specific exclusion of infants with sepsis or suspected sepsis, Schmutz et al studied the range of ANC in >30,000 CBCs obtained within 72 hours of birth from infants of 23 to 42 weeks completed gestation including 852 infants with <28 weeks gestation41. The upper and lower limits for the ANC from birth to the 3rd day of life were 1500 to 41000/µL; from the 3rd day until the 10th day of life counts ranged from 1100 to 15300/µL.
Hornik et al retrospectively examined the utility of the CBC and WBC indices (total leukocyte counts, immature to total neutrophil (I/T) ratio and absolute neutrophil counts [ANC]) from >200,000 infants (including both preterm and term infants), and concluded no CBC parameter had sufficient utility for identifying infants with early-onset or late-onset sepsis42,43. The area under receiver operating characteristics curves (AUC) was ≤0.668 for all individual indices including WBC, I/T, ANC, and platelet counts highlighting the limited utility of the CBC and in particular the WBC to identify infants with early-onset sepsis. A significant proportion of infants (14.4%) with LOS had normal CBC indices (WBC count 5000/mm3–19,000/mm3, ANC ≥1500/mm3, I/T ratio <0.2)42. In a study investigating the diagnostic value of waiting a period of time to obtain a CBC after birth to identify near-term (34–36 weeks completed gestation) and term infants with blood culture-positive sepsis Newman concluded, “…even when the CBC is optimally interpreted, decisions about antibiotic treatment should remain highly dependent on maternal risk factors and newborn symptoms of infection”40.
While pediatricians/neonatologists often reply upon a “shift to the left” to identify infected infants, the identification of band forms is problematic. Van der Meer et al examined the range of variance for band form neutrophils by surveying >750 technician responses from >100 laboratories in Europe44. All observers received identical slides with 100 Giemsa-stained cells from a patient with sepsis. They reported wide intra- and inter-laboratory variation in interpretations for neutrophils (15–72%, SD 11%) and for band forms (4–64%, SD 11%). This study suggests the enormous variability of interpretation of the band count and thus the I/T ratio may limit use of the I/T ratio as a definition criterion.
Core temperature is inaccurate to define sepsis in term or preterm neonates
The use of an abnormal core temperature as a criterion for sepsis has significant limitations in preterm infants. Preterm neonates manifest a baseline lack of temperature maintenance due to physiologic immaturity that requires servo-controlled incubators. Thus, hypothermia may be secondary to inadequate provision of heat rather than sepsis. Among 395 symptomatic preterm infants with blood culture-positive late-onset sepsis (LOS), only 10.8% had temperature instability that occurred 24 hours before or after the first positive blood culture (positive predictive value 10.2%)34. Neonates, particularly preterm neonates, rarely manifest fever greater than 38°C even with sepsis and septic shock, and are more likely to manifest temperature instability or hypothermia. Thus, an abnormal core temperature is a difficult criterion to interpret in the setting of neonatal SIRS/sepsis. Voora et al showed that among 10,092 term newborns, 1% (n=100) developed an axillary or rectal temperature ≥37.8C within 4 days of birth and only 10% of those with a temperature ≥37.8°C (n=10) had a positive blood culture45.
Interpretation of blood culture results in defining sepsis in term or preterm neonates (Type I and Type II errors)
When a potential pathogen grows from a blood culture, it is important to distinguish true infection from a potential contaminant (type I error). As many as 62% of extremely low birth weight infants who survive >12 hours after birth have a positive blood culture during their hospitalization3. Coagulase-negative Staphylococci (CoNS) represents greater than 50% of isolated bacteria from blood cultures of preterm infants in the United States and many centers worldwide16,46,47. Management of a single blood culture positive for CoNS varies widely, from careful observation to aggressive treatment, which implies some clinicians may view it as a contaminant48. The rate of false positive blood cultures (of which >67% are due to CoNS) is directly proportional to the age of the child and is as high as 17% in infants <12 weeks of age49.
Although a positive culture is often considered the “gold standard” definition of infection, culture-negative, clinical sepsis is considered a real entity in all age groups. Furthermore, a pathogen may be identified in as little as 36–51% of cases of sepsis in adults50,51 even though sepsis is defined as SIRS in response to an inciting infection. A similar rate of culture-negative sepsis is seen in pediatric patients even in the setting of shock18. In a study of newborns with unequivocal infection documented at autopsy, premortem blood cultures were negative in 14% of cases52. In another study of 92 neonates ≥34 weeks with culture-positive bacterial meningitis, 35 (38%) had negative blood cultures53. When blood and other sterile site cultures are negative, but the infant manifests signs concerning for infection they are considered to have clinical sepsis. In neonates, this clinical scenario is far more common than blood-culture positive sepsis54, and represented nearly 60% of the subjects enrolled in the recent International Neonatal Immunotherapy Study (INIS) that examined treatment of neonatal sepsis with intravenous immune globulin1. Furthermore, neonates often have low colony count bacteremia and when an insufficient volume of blood is obtained for culture, the blood culture may be falsely negative (type II error)55. Finally, the possibility of a non-bacterial cause of infection must also be considered. Fungal and viral infections may also generate a systemic inflammatory response and sepsis. There is increasing evidence for novel viral pathogens associated with sepsis-like syndrome in preterm infants (e.g., echovirus, enterovirus, parechovirus, coxsackie, adenovirus, parainfluenza, rhinovirus, coronavirus)56–59.
How should we move forward?
We must first establish a consensus definition of neonatal sepsis to refine future observational studies and clinical trial designs. The limited diagnostic accuracy of common laboratory tests (including the WBC indices and acute phase reactants) for diagnosing neonatal sepsis is well described (Supplemental table 2) and has been reviewed in detail elsewhere60,61. Improved diagnostic accuracy may come from novel microscale-based molecular methods including 16sRNA DNA PCR, genome-wide expression profiling, flow cytometry-based blood analysis, and proteomic approaches. For example, by first examining patients that met the consensus definition for pediatric septic shock, Wong et al used genome-wide expression profiling on whole blood to demonstrate multiple subclinical molecular endotypes62. Utilization of these robust methods within a definitive disease framework is highly likely to reveal markers that facilitate early identification of patients at high risk of poor outcomes and thus permit stratification risk for future clinical trials. However, in the absence of a consensus definition for sepsis, sensitive molecular diagnostic tests derived from subjects in observational studies where multiple sepsis definitions are used (Supplemental table 1) will only further amplify the heterogeneity of the populations and would thus be at risk of demonstrating poor diagnostic accuracy between clinical cohorts.
To complement classic and modern molecular laboratory testing, defining neonatal sepsis should include a severity of illness description. The PIRO model (predisposition, insult/infection, response, organ dysfunction63) is one example of a severity of illness model that has been used to study sepsis in adults and identify patients at high risk of mortality64,65. Examples of predisposition factors for sepsis in neonates would include maternal risk factors (e.g., preterm premature rupture of membranes or vaginal colonization with group B streptococcus66) and neonatal risk factors (prematurity or need for invasive monitoring). Infection factors might include the type and antimicrobial resistance pattern of the pathogen (bacteria, virus, or fungus-if identified) and the site of infection (e.g. blood, urine, CSF, trachea, multi-site or disseminated). Host response factors might encompass the inflammatory response (longitudinal plasma cytokines and acute phase reactants), severity and duration of clinical signs (e.g., tachypnea, increased oxygen requirement, apnea, tachycardia) and laboratory data such as neutropenia. Host response assessments may permit identification of temporal stages of sepsis pathology amenable to different treatment approaches. Organ dysfunction factors might include the requirement for inotropes, intubation for respiratory failure, oliguria, or coagulopathy. Importantly, no matter what criteria constitute the initial consensus definition for sepsis, revision and refinement of the definition should be expected to occur as new data is acquired.
Potential limitations of a consensus definition of sepsis
The present consensus definitions for sepsis in children and adults are threshold-based and thus static. A static definition of sepsis has potential advantages, but also has inherent limitations including the inability to incorporate change in status over time. For example, a patient may meet criteria (laboratory or clinical) for the definition of sepsis at one point in their disease process but not at another. Thus, a static definition of sepsis will likely be associated with limitations in diagnostic accuracy because sepsis is a dynamic, complex and heterogeneous condition67. This challenging feature of sepsis, in addition to the biology/cutoff value used for biomarkers and variability of sepsis definitions between studies, likely contributes to the frequently limited positive predictive value but high negative predictive value seen for clinical signs and common laboratory tests used in neonates (Supplemental table 2). Although important for diagnostic accuracy, time is a difficult variable to integrate into the static decision to enroll a patient in a prospective interventional trial. Therefore, the variable of time (e.g. time of clinical presentation/biomarker measurement, duration of clinical and laboratory signs) should be collected in diagnostic studies and RCTs. Another potential limitation of a consensus definition is the background of the consensus members. A homogeneous consensus (e.g. all newborn critical care providers) is at risk of reflecting the bias of common training. Therefore, any expert consensus should have diversity among its members. Lastly, the consensus should only defer to expert opinion when data is not available. This last point illustrates the need to collect data for diagnostic and interventional studies in order to refine the criteria that constitute the definition of neonatal sepsis. Any useful definition would need to address these points and would need validation with outcomes especially in preterm neonates. A consensus definition is not meant to be the last word on how to define sepsis. Rather, the establishment of an accepted definition to be used by clinical researchers is but the first of many steps towards improving outcomes for neonates with sepsis. We have shown the present definition of neonatal sepsis is both static and variable; the combination of which we believe is entirely inadequate to allow progress.
Summary
Sepsis is a common and devastating problem in the NICU. Diagnostic and clinical interventional trials focused on neonatal sepsis are significantly hampered by use of a widely diverse definition for this disease. The first step toward addressing the poor outcomes is to reduce the variability in our definition of sepsis through the establishment of a consensus definition. Though intended to facilitate study of this important disease in all children, the pediatric consensus definitions for sepsis are not accurate for term neonates and were not created for preterm neonates. Thus, consensus definitions for sepsis in term and preterm infants are needed so that future epidemiologic studies and trials of diagnostic and therapeutic interventions can be interpreted and implemented. Definitions are also needed to help clinicians in determining true sepsis and providing appropriate clinical care. It is therefore critical that a consensus conference be held to establish evidence-based neonate-specific sepsis definitions and to develop a research agenda to validate these definitions.
Supplementary Material
Acknowledgments
Funding source: This project was done with no specific support.
The authors wish to thank Dr. Bill Walsh and Dr. Jeff Reese for their intellectual input.
Abbreviations used
- NICU
Neonatal intensive care unit
- SIRS
systemic inflammatory response syndrome
- ACCP
American College of Chest Physicians
- SCCM
Society of Critical Care Medicine
- MODS
multiple organ dysfunction syndrome
- WBC
white blood cell
- EOS
early-onset sepsis
- LOS
late-onset sepsis
- ANC
absolute neutrophil count
- I/T ratio
immature to total neutrophil ratio
- CBC
complete blood count
- VLBW
very low birth weight
- CRP
C-reactive protein
- APR
acute phase reactant
- CoNS
coagulase-negative Staphylococci
- SD
standard deviation
- AUC
area under curve
Footnotes
Financial Disclosure Statement for all authors: No author has any financial relationships that could be broadly relevant to the work.
Contributor’s statements:
James L. Wynn: Dr. Wynn conceived the special article topic, wrote the first draft, reviewed and revised the manuscript, and approved the final manuscript as submitted.
Hector R. Wong: Dr. Wong reviewed and revised the manuscript, and approved the final manuscript as submitted.
Thomas P. Shanley: Dr. Shanley reviewed and revised the manuscript, and approved the final manuscript as submitted.
Matthew J. Bizzarro: Dr. Bizzarro reviewed and revised the manuscript, and approved the final manuscript as submitted.
Lisa Saiman: Dr. Saiman reviewed and revised the manuscript, and approved the final manuscript as submitted.
Richard A. Polin: Dr. Polin reviewed and revised the manuscript, and approved the final manuscript as submitted.
References
- 1.Brocklehurst P, Farrell B, King A, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med. 2011;365(13):1201–1211. doi: 10.1056/NEJMoa1100441. [DOI] [PubMed] [Google Scholar]
- 2.Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med. 2013;14(7):686–693. doi: 10.1097/PCC.0b013e3182917fad. [DOI] [PubMed] [Google Scholar]
- 3.Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443–456. doi: 10.1542/peds.2009-2959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Prabhudas M, Adkins B, Gans H, et al. Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol. 2011;12(3):189–194. doi: 10.1038/ni0311-189. [DOI] [PubMed] [Google Scholar]
- 5.Wynn JL, Neu J, Moldawer LL, Levy O. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol. 2009;29(2):79–88. doi: 10.1038/jp.2008.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292(19):2357–2365. doi: 10.1001/jama.292.19.2357. [DOI] [PubMed] [Google Scholar]
- 7.Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2–8. doi: 10.1097/01.PCC.0000149131.72248.E6. [DOI] [PubMed] [Google Scholar]
- 8.Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–1655. doi: 10.1378/chest.101.6.1644. [DOI] [PubMed] [Google Scholar]
- 9.Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37(2):666–688. doi: 10.1097/CCM.0b013e31819323c6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17–60. doi: 10.1007/s00134-007-0934-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hofer N, Zacharias E, Muller W, Resch B. Performance of the definitions of the systemic inflammatory response syndrome and sepsis in neonates. J Perinat Med. 2012;40(5):587–590. doi: 10.1515/jpm-2011-0308. [DOI] [PubMed] [Google Scholar]
- 12.Auriti C, Fiscarelli E, Ronchetti MP, et al. Procalcitonin in detecting neonatal nosocomial sepsis. Arch Dis Child Fetal Neonatal Ed. 2012;97(5):F368–F370. doi: 10.1136/fetalneonatal-2010-194100. [DOI] [PubMed] [Google Scholar]
- 13.Wu TW, Tabangin M, Kusano R, Ma Y, Ridsdale R, Akinbi H. The utility of serum hepcidin as a biomarker for late-onset neonatal sepsis. J Pediatr. 2013;162(1):67–71. doi: 10.1016/j.jpeds.2012.06.010. [DOI] [PubMed] [Google Scholar]
- 14.Kuhn P, Messer J, Paupe A, et al. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia. J Pediatr. 2009;155(3):324–330. e321. doi: 10.1016/j.jpeds.2009.03.019. [DOI] [PubMed] [Google Scholar]
- 15.Been JV, Rours IG, Kornelisse RF, et al. Histologic chorioamnionitis, fetal involvement, and antenatal steroids: effects on neonatal outcome in preterm infants. Am J Obstet Gynecol. 2009;201587(6):e581–e588. doi: 10.1016/j.ajog.2009.06.025. [DOI] [PubMed] [Google Scholar]
- 16.Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285–291. doi: 10.1542/peds.110.2.285. [DOI] [PubMed] [Google Scholar]
- 17.Madan JC, Salari RC, Saxena D, et al. Gut microbial colonisation in premature neonates predicts neonatal sepsis. Arch Dis Child Fetal Neonatal Ed. 2012;97(6):F456–F462. doi: 10.1136/fetalneonatal-2011-301373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wynn JL, Cvijanovich NZ, Allen GL, et al. The Influence of Developmental Age on the Early Transcriptomic Response of Children with Septic Shock. Molecular Medicine. 2011;17(11–12):1146–1156. doi: 10.2119/molmed.2011.00169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest. 2010;120(8):2989–3000. doi: 10.1172/JCI40196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA. 2009;302(13):1421–1428. doi: 10.1001/jama.2009.1403. [DOI] [PubMed] [Google Scholar]
- 21.Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102(4):E41. doi: 10.1542/peds.102.4.e41. [DOI] [PubMed] [Google Scholar]
- 22.Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J. 2003;22(5):430–434. doi: 10.1097/01.inf.0000068206.11303.dd. [DOI] [PubMed] [Google Scholar]
- 23.Dutta S, Reddy R, Sheikh S, Kalra J, Ray P, Narang A. Intrapartum antibiotics and risk factors for early onset sepsis. Arch Dis Child Fetal Neonatal Ed. 2010;95(2):F99–F103. doi: 10.1136/adc.2009.163220. [DOI] [PubMed] [Google Scholar]
- 24.Chaaban H, Singh K, Huang J, Siryaporn E, Lim YP, Padbury JF. The role of inter-alpha inhibitor proteins in the diagnosis of neonatal sepsis. J Pediatr. 2009;154(4):620–622. e621. doi: 10.1016/j.jpeds.2008.10.008. [DOI] [PubMed] [Google Scholar]
- 25.Poindexter BB, Ehrenkranz RA, Stoll BJ, et al. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics. 2004;113(5):1209–1215. doi: 10.1542/peds.113.5.1209. [DOI] [PubMed] [Google Scholar]
- 26.Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics. 2008;122(4):693–700. doi: 10.1542/peds.2007-3007. [DOI] [PubMed] [Google Scholar]
- 27.Weisman LE, Stoll BJ, Kueser TJ, et al. Intravenous immune globulin therapy for early-onset sepsis in premature neonates. J Pediatr. 1992;121(3):434–443. doi: 10.1016/s0022-3476(05)81802-5. [DOI] [PubMed] [Google Scholar]
- 28.Fanaroff AA, Korones SB, Wright LL, et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 1994;330(16):1107–1113. doi: 10.1056/NEJM199404213301602. [DOI] [PubMed] [Google Scholar]
- 29.Klinger G, Levy I, Sirota L, Boyko V, Lerner-Geva L, Reichman B. Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics. 2010;125(4):e736–e740. doi: 10.1542/peds.2009-2017. [DOI] [PubMed] [Google Scholar]
- 30.Tita AT, Landon MB, Spong CY, et al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med. 2009;360(2):111–120. doi: 10.1056/NEJMoa0803267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Strunk T, Doherty D, Jacques A, et al. Histologic chorioamnionitis is associated with reduced risk of late-onset sepsis in preterm infants. Pediatrics. 2012;129(1):e134–e141. doi: 10.1542/peds.2010-3493. [DOI] [PubMed] [Google Scholar]
- 32.Mercer BM, Crouse DT, Goldenberg RL, et al. The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes. Am J Obstet Gynecol. 2012;206(2):145, e141–e149. doi: 10.1016/j.ajog.2011.08.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kingsmore SF, Kennedy N, Halliday HL, et al. Identification of diagnostic biomarkers for infection in premature neonates. Mol Cell Proteomics. 2008;7(10):1863–1875. doi: 10.1074/mcp.M800175-MCP200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J. 1998;17(7):593–598. doi: 10.1097/00006454-199807000-00004. [DOI] [PubMed] [Google Scholar]
- 35.Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332. doi: 10.1016/j.ajic.2008.03.002. [DOI] [PubMed] [Google Scholar]
- 36.Kermorvant-Duchemin E, Laborie S, Rabilloud M, Lapillonne A, Claris O. Outcome and prognostic factors in neonates with septic shock. Pediatr Crit Care Med. 2008;9(2):186–191. doi: 10.1097/PCC.0b013e31816689a8. [DOI] [PubMed] [Google Scholar]
- 37.Griffin MP, Lake DE, Moorman JR. Heart rate characteristics and laboratory tests in neonatal sepsis. Pediatrics. 2005;115(4):937–941. doi: 10.1542/peds.2004-1393. [DOI] [PubMed] [Google Scholar]
- 38.Wynn JL, Hansen NI, Das A, et al. Early sepsis does not increase the risk of late sepsis in very low birth weight neonates. J Pediatr. 2013;162(5):942–948. e943. doi: 10.1016/j.jpeds.2012.11.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mitha A, Foix-L'Helias L, Arnaud C, et al. Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants. Pediatrics. 2013;132(2):e372–e380. doi: 10.1542/peds.2012-3979. [DOI] [PubMed] [Google Scholar]
- 40.Newman TB, Puopolo KM, Wi S, Draper D, Escobar GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics. 2010;126(5):903–909. doi: 10.1542/peds.2010-0935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Schmutz N, Henry E, Jopling J, Christensen RD. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol. 2008;28(4):275–281. doi: 10.1038/sj.jp.7211916. [DOI] [PubMed] [Google Scholar]
- 42.Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31(8):803–807. doi: 10.1097/INF.0b013e31825691e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31(8):799–802. doi: 10.1097/INF.0b013e318256905c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.van der Meer W, van Gelder W, de Keijzer R, Willems H. Does the band cell survive the 21st century? Eur J Haematol. 2006;76(3):251–254. doi: 10.1111/j.1600-0609.2005.00597.x. [DOI] [PubMed] [Google Scholar]
- 45.Voora S, Srinivasan G, Lilien LD, Yeh TF, Pildes RS. Fever in full-term newborns in the first four days of life. Pediatrics. 1982;69(1):40–44. [PubMed] [Google Scholar]
- 46.Hornik CP, Fort P, Clark RH, et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev. 2012;88(Suppl 2):S69–S74. doi: 10.1016/S0378-3782(12)70019-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Cohen-Wolkowiez M, Moran C, Benjamin DK, et al. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J. 2009;28(12):1052–1056. doi: 10.1097/inf.0b013e3181acf6bd. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Rubin LG, Sanchez PJ, Siegel J, Levine G, Saiman L, Jarvis WR. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics. 2002;110(4):e42. doi: 10.1542/peds.110.4.e42. [DOI] [PubMed] [Google Scholar]
- 49.Norberg A, Christopher NC, Ramundo ML, Bower JR, Berman SA. Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter. JAMA. 2003;289(6):726–729. doi: 10.1001/jama.289.6.726. [DOI] [PubMed] [Google Scholar]
- 50.Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554. doi: 10.1056/NEJMoa022139. [DOI] [PubMed] [Google Scholar]
- 51.Seymour CW, Iwashyna TJ, Cooke CR, Hough CL, Martin GS. Marital status and the epidemiology and outcomes of sepsis. Chest. 2010;137(6):1289–1296. doi: 10.1378/chest.09-2661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Squire E, Favara B, Todd J. Diagnosis of neonatal bacterial infection: hematologic and pathologic findings in fatal and nonfatal cases. Pediatrics. 1979;64(1):60–64. [PubMed] [Google Scholar]
- 53.Garges HP, Moody MA, Cotten CM, et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics. 2006;117(4):1094–1100. doi: 10.1542/peds.2005-1132. [DOI] [PubMed] [Google Scholar]
- 54.Lukacs SL, Schrag SJ. Clinical sepsis in neonates and young infants, United States, 1988–2006. J Pediatr. 2012;160(6):960–965. e961. doi: 10.1016/j.jpeds.2011.12.023. [DOI] [PubMed] [Google Scholar]
- 55.Schelonka RL, Chai MK, Yoder BA, Hensley D, Brockett RM, Ascher DP. Volume of blood required to detect common neonatal pathogens. J Pediatr. 1996;129(2):275–278. doi: 10.1016/s0022-3476(96)70254-8. [DOI] [PubMed] [Google Scholar]
- 56.Smit PM, Pronk SM, Kaandorp JC, et al. RT-PCR detection of respiratory pathogens in newborn children admitted to a neonatal medium care unit. Pediatr Res. 2013;73(3):355–361. doi: 10.1038/pr.2012.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Kusuhara K, Saito M, Sasaki Y, et al. An echovirus type 18 outbreak in a neonatal intensive care unit. Eur J Pediatr. 2008;167(5):587–589. doi: 10.1007/s00431-007-0516-x. [DOI] [PubMed] [Google Scholar]
- 58.Verboon-Maciolek MA, Krediet TG, Gerards LJ, Fleer A, van Loon TM. Clinical and epidemiologic characteristics of viral infections in a neonatal intensive care unit during a 12-year period. Pediatr Infect Dis J. 2005;24(10):901–904. doi: 10.1097/01.inf.0000180471.03702.7f. [DOI] [PubMed] [Google Scholar]
- 59.Civardi E, Tzialla C, Baldanti F, Strocchio L, Manzoni P, Stronati M. Viral outbreaks in neonatal intensive care units: What we do not know. Am J Infect Control. 2013;41(10):854–856. doi: 10.1016/j.ajic.2013.01.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Benitz WE. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol. 2010;37(2):421–438. doi: 10.1016/j.clp.2009.12.001. [DOI] [PubMed] [Google Scholar]
- 61.Srinivasan L, Harris MC. New technologies for the rapid diagnosis of neonatal sepsis. Current opinion in pediatrics. 2012;24(2):165–171. doi: 10.1097/MOP.0b013e3283504df3. [DOI] [PubMed] [Google Scholar]
- 62.Wong HR, Cvijanovich NZ, Allen GL, et al. Validation of a gene expression-based subclassification strategy for pediatric septic shock. Critical care medicine. 2011;39(11):2511–2517. doi: 10.1097/CCM.0b013e3182257675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical care medicine. 2003;31(4):1250–1256. doi: 10.1097/01.CCM.0000050454.01978.3B. [DOI] [PubMed] [Google Scholar]
- 64.Granja C, Povoa P, Lobo C, Teixeira-Pinto A, Carneiro A, Costa-Pereira A. The predisposition, infection, response and organ failure (Piro) sepsis classification system: results of hospital mortality using a novel concept and methodological approach. PLoS One. 2013;8(1):e53885. doi: 10.1371/journal.pone.0053885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Howell MD, Talmor D, Schuetz P, Hunziker S, Jones AE, Shapiro NI. Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Critical care medicine. 2011;39(2):322–327. doi: 10.1097/CCM.0b013e3182037a8e. [DOI] [PubMed] [Google Scholar]
- 66.Escobar GJ, Puopolo KM, Wi S, et al. Stratification of risk of early-onset sepsis in newborns >=34 weeks' gestation. Pediatrics. 2014;133(1):30–36. doi: 10.1542/peds.2013-1689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Lynn LA. The diagnosis of sepsis revisited - a challenge for young medical scientists in the 21st century. Patient Saf Surg. 2014;8(1):1. doi: 10.1186/1754-9493-8-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Bassler D, Stoll BJ, Schmidt B, et al. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics. 2009;123(1):313–318. doi: 10.1542/peds.2008-0377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr Infect Dis J. 2011;30(11):937–941. doi: 10.1097/INF.0b013e318223bad2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928–2003. Pediatrics. 2005;116(3):595–602. doi: 10.1542/peds.2005-0552. [DOI] [PubMed] [Google Scholar]
- 71.Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants >/=2000 grams at birth: A population-based study. Pediatrics. 2000;106(2 Pt 1):256–263. doi: 10.1542/peds.106.2.256. [DOI] [PubMed] [Google Scholar]
- 72.Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed. 2011;96(1):F9–F14. doi: 10.1136/adc.2009.178798. [DOI] [PubMed] [Google Scholar]
- 73.Puopolo KM, Draper D, Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics. 2011;128(5):e1155–e1163. doi: 10.1542/peds.2010-3464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Kudawla M, Dutta S, Narang A. Validation of a clinical score for the diagnosis of late onset neonatal septicemia in babies weighing 1000–2500 g. J Trop Pediatr. 2008;54(1):66–69. doi: 10.1093/tropej/fmm065. [DOI] [PubMed] [Google Scholar]
- 75.Streimish I, Bizzarro M, Northrup V, et al. Neutrophil CD64 as a diagnostic marker in neonatal sepsis. Pediatr Infect Dis J. 2012;31(7):777–781. doi: 10.1097/INF.0b013e318256fb07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Weirich E, Rabin RL, Maldonado Y, et al. Neutrophil CD11b expression as a diagnostic marker for early-onset neonatal infection. J Pediatr. 1998;132(3 Pt 1):445–451. doi: 10.1016/s0022-3476(98)70018-6. [DOI] [PubMed] [Google Scholar]
- 77.Lacaze-Masmonteil T, Rosychuk RJ, Robinson JL. Value of a single C-reactive protein measurement at 18 h of age. Arch Dis Child Fetal Neonatal Ed. 2014;99(1):F76–F79. doi: 10.1136/archdischild-2013-303984. [DOI] [PubMed] [Google Scholar]
- 78.Franz AR, Bauer K, Schalk A, et al. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics. 2004;114(1):1–8. doi: 10.1542/peds.114.1.1. [DOI] [PubMed] [Google Scholar]
- 79.Laborada G, Rego M, Jain A, et al. Diagnostic value of cytokines and C-reactive protein in the first 24 hours of neonatal sepsis. Am J Perinatol. 2003;20(8):491–501. doi: 10.1055/s-2003-45382. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.